JD Vance is a Yale Law School graduate who worked for biotech firms and venture capital. In a world of fake-ass politicians, no one is more transparently fake than JD Vance.
JD Vance says of the Middle East that it's "a region of the world made up of countries whose name I couldn't even pronounce"
October 27, 2026 at 6:18 PM
JD Vance is a Yale Law School graduate who worked for biotech firms and venture capital. In a world of fake-ass politicians, no one is more transparently fake than JD Vance.
There is no equity. The work they fund will not benefit the public. These efforts are wolves in sheep’s clothing meant to engender good will from critical constituencies—biotech, engineering, tech, space, etc—who could feasibly mount an offensive against these unpopular oligarchs.
October 27, 2026 at 4:29 PM
There is no equity. The work they fund will not benefit the public. These efforts are wolves in sheep’s clothing meant to engender good will from critical constituencies—biotech, engineering, tech, space, etc—who could feasibly mount an offensive against these unpopular oligarchs.
‘Designer baby’ start-ups test limits of biotech taboo ft.trib.al/Oys8oI3
‘Designer baby’ start-ups test limits of biotech taboo
Failed ventures have not cooled investor appetite for gene-editing groups and one of the most contested frontiers in science
ft.trib.al
October 25, 2026 at 5:34 AM
‘Designer baby’ start-ups test limits of biotech taboo ft.trib.al/Oys8oI3
The Danish biotech said an experimental drug cut the risk of death and disease progression for ovarian-cancer patients in a late-stage clinical trial. on.wsj.com/3UmnoNg
Genmab Shares Jump After Positive Cancer Study Results
The Danish biotech said an experimental drug cut the risk of death and disease progression for ovarian-cancer patients in a late-stage clinical trial.
on.wsj.com
October 26, 2026 at 11:48 AM
The Danish biotech said an experimental drug cut the risk of death and disease progression for ovarian-cancer patients in a late-stage clinical trial. on.wsj.com/3UmnoNg
leave the dogs alone
October 26, 2026 at 7:38 PM
leave the dogs alone
Yeah the neurodivergent small bean act suddenly goes away when she needs to speak biotech business jargon. Just part of her mysterious brilliance I guess!
October 25, 2026 at 7:21 AM
Yeah the neurodivergent small bean act suddenly goes away when she needs to speak biotech business jargon. Just part of her mysterious brilliance I guess!
$ACTU prices $11M offering at $0.45/share + 15.5M warrants, boosting liquidity but causing dilution. More biotech: $ARTV $KNSA $CAMP $ZURA $NAUT $PDSB $MBRX $IMNN $SPRC.
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
Daily Updates 10/27/26
export-download.canva.com
October 27, 2026 at 8:30 PM
$ACTU prices $11M offering at $0.45/share + 15.5M warrants, boosting liquidity but causing dilution. More biotech: $ARTV $KNSA $CAMP $ZURA $NAUT $PDSB $MBRX $IMNN $SPRC.
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
The Donut Labs battery of biotech. PR scheme to raise funds.
Also, Colossal Biosciences is full of it (and they did not actually make “dire wolves”):
www.newscientist.com/article/2481...
www.newscientist.com/article/2481...
Colossal scientist now admits they haven’t really made dire wolves | New Scientist
Despite a huge media fanfare in which Colossal Biosciences claimed to have resurrected the extinct dire wolf, the company's chief scientist now concedes that the animals are merely modified grey wolve...
www.newscientist.com
October 23, 2026 at 3:03 PM
The Donut Labs battery of biotech. PR scheme to raise funds.
I make significantly more money in an entry-level biotech role as a Japanese salaryman 2 decades older than me
October 25, 2026 at 4:36 PM
I make significantly more money in an entry-level biotech role as a Japanese salaryman 2 decades older than me
SEND THIS TO EVERY MEDICAL PROFESSIONAL YOU KNOW. DOCTORS, NURSES, STUDENTS, BIOLOGISTS, PROFESSORS.
THE ENTIRE MEDICAL COMMUNITY NEEDS TO WAKE UP NOW
www.vcinfodocs.com/unregulated-...
VCs are buying entire hospital systems, all the health care data in the world, experimentation colonies
THE ENTIRE MEDICAL COMMUNITY NEEDS TO WAKE UP NOW
www.vcinfodocs.com/unregulated-...
VCs are buying entire hospital systems, all the health care data in the world, experimentation colonies
October 28, 2026 at 7:17 PM
SEND THIS TO EVERY MEDICAL PROFESSIONAL YOU KNOW. DOCTORS, NURSES, STUDENTS, BIOLOGISTS, PROFESSORS.
THE ENTIRE MEDICAL COMMUNITY NEEDS TO WAKE UP NOW
www.vcinfodocs.com/unregulated-...
VCs are buying entire hospital systems, all the health care data in the world, experimentation colonies
THE ENTIRE MEDICAL COMMUNITY NEEDS TO WAKE UP NOW
www.vcinfodocs.com/unregulated-...
VCs are buying entire hospital systems, all the health care data in the world, experimentation colonies
Aspen Neuroscience, Bambusa Therapeutics launch US IPOs as biotech boom rolls on reut.rs/48eNHZ9
Aspen Neuroscience, Bambusa Therapeutics launch US IPOs as biotech boom rolls on
Drug developers Aspen Neuroscience and Bambusa Therapeutics launched their US initial public offering roadshows on Monday, adding to a wave of issuers from the biotech industry that have tapped the fall IPO window.
reut.rs
October 26, 2026 at 7:05 PM
Aspen Neuroscience, Bambusa Therapeutics launch US IPOs as biotech boom rolls on reut.rs/48eNHZ9
Marianna Prokopi-Demetriades takes cancer biotech beyond the laboratory
Marianna Prokopi-Demetriades takes cancer biotech beyond the laboratory
cyprus-mail.com
October 27, 2026 at 3:04 PM
Marianna Prokopi-Demetriades takes cancer biotech beyond the laboratory
A loosely defined joint venture ban in Treasury’s draft COINS rule could sharply curtail China biotech deals, experts say.
Treasury's COINS rule draft would narrow the path for China biotech dealmaking, experts say
Treasury’s draft COINS rules could sweep up complex China biotech collaborations as banned joint ventures, though simple licensing deals may escape.
endpoints.news
October 27, 2026 at 8:42 PM
A loosely defined joint venture ban in Treasury’s draft COINS rule could sharply curtail China biotech deals, experts say.
Wisconsin is a leader in biotechnology and personalized medicine. That’s why I worked to bring a Tech Hub to our state. It was great to be in Madison with so many incredible leaders who are working to grow our biotech sector and improve health care for patients.
October 25, 2026 at 11:34 PM
Wisconsin is a leader in biotechnology and personalized medicine. That’s why I worked to bring a Tech Hub to our state. It was great to be in Madison with so many incredible leaders who are working to grow our biotech sector and improve health care for patients.
Y el descarrile llega con «Biotech Is Godzilla», punk/crust total de la mano de Jello Biafra de Dead Kennedys. Rápida, magufa, muy divertida y con un solo loquísimo
Biotech Is Godzilla
YouTube video by Sepultura - Topic
www.youtube.com
October 26, 2026 at 12:13 PM
Y el descarrile llega con «Biotech Is Godzilla», punk/crust total de la mano de Jello Biafra de Dead Kennedys. Rápida, magufa, muy divertida y con un solo loquísimo
Friend's husband who works in biotech says this is simply what biotech is like, so yeah yolo.
Biotech execs: "It's one administrative assistant, Michael. How much could it cost? $130,000?"
October 24, 2026 at 9:06 PM
Friend's husband who works in biotech says this is simply what biotech is like, so yeah yolo.
Curious how we feel about defense and biotech startup Warhound’s plans to genetically engineer dogs for military use and the like? This is it 🤦
October 23, 2026 at 10:51 PM
Curious how we feel about defense and biotech startup Warhound’s plans to genetically engineer dogs for military use and the like? This is it 🤦
How do you stay updated on biotech trends during your commute? 🚗💨 Check out Pharm2Market for top podcasts like BioSpace, Fierce Biotech, and Target Space to catch up on the go!
Got questions? Pharm2Market's got the answers.
bit.ly/3UfeaSG #Biotech #Networking #CareerOpportunities #Sales
Got questions? Pharm2Market's got the answers.
bit.ly/3UfeaSG #Biotech #Networking #CareerOpportunities #Sales
October 28, 2026 at 3:47 PM
How do you stay updated on biotech trends during your commute? 🚗💨 Check out Pharm2Market for top podcasts like BioSpace, Fierce Biotech, and Target Space to catch up on the go!
Got questions? Pharm2Market's got the answers.
bit.ly/3UfeaSG #Biotech #Networking #CareerOpportunities #Sales
Got questions? Pharm2Market's got the answers.
bit.ly/3UfeaSG #Biotech #Networking #CareerOpportunities #Sales
Biotech researcher is such a funny job to pull.
October 28, 2026 at 3:15 PM
Biotech researcher is such a funny job to pull.
A type of targeted chemotherapy developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer. https://www.statnews.com/2026/10/26/merck-kelun-sac-tmt-endometrial-cancer-study-esmo-2026/
Merck ADC drug cut risk of death by one-third in advanced endometrial cancer
A Phase 3 trial of a targeted drug developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer.
www.statnews.com
October 26, 2026 at 4:52 PM
A type of targeted chemotherapy developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer. https://www.statnews.com/2026/10/26/merck-kelun-sac-tmt-endometrial-cancer-study-esmo-2026/
Biotech stocks are surging. How investors can play the new drug innovation boom
Biotech stocks are surging. How investors can play the new drug innovation boom
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
cnb.cx
October 24, 2026 at 1:13 PM
Biotech stocks are surging. How investors can play the new drug innovation boom
US targets Chinese biotech investment, under proposed COINS expansion, but licensing deals remain exempt
www.pharmaceutical-technology.com/news/us-targ...
#pharma #biotech
www.pharmaceutical-technology.com/news/us-targ...
#pharma #biotech
US targets Chinese biotech investment, but licensing deals remain exempt - Pharmaceutical Technology
Numerous types of equity deals involving Chinese biotech, including the popular NewCo model, will be impacted by the proposed rule.
www.pharmaceutical-technology.com
October 26, 2026 at 11:12 AM
US targets Chinese biotech investment, under proposed COINS expansion, but licensing deals remain exempt
www.pharmaceutical-technology.com/news/us-targ...
#pharma #biotech
www.pharmaceutical-technology.com/news/us-targ...
#pharma #biotech
